Drugs / Trimethoprim/Sulfamethoxazole
Trials 0
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Comparator or background therapy1 trial | ||||||
| Phase 2 | NCT01594827 Background | Oct 2012 → Dec 2017 | cystic fibrosis | Johns Hopkins University | Completed | No outcome recorded |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | Trimethoprim/Sulfamethoxazole | ClinicalTrials.gov intervention name — accepted as the source's own label NCT01594827 ↗ |
| Route | Oral | “Oral trimethoprim/sulfamethoxazole” NCT01594827 ↗ |